Literature DB >> 9395

Phosphofructokinase. III. Correlation of the regulatory kinetic and molecular properties of the rabbit muscle enzyme.

C Frieden, H R Gilbert, P E Bock.   

Abstract

It is shown that the degree of regulatory kinetic behavior of rabbit muscle phosphofructokinase increases at a given pH and lower temperatures, as well as at a given temperature and lower pH values. It is also shown that the regulatory kinetic behavior which appears at lower pH values is inherent in the tetrameric (active) form of the enzyme. We conclude that a portion of the mechanism proposed previously (Bock, P.E., and Frieden, C. (1976) J. Biol. Chem. 251, 5630-5636) to describe the pH and temperature-dependent inactivation or reactivation may also be used to explain the pH and temperature-dependent regulatory kinetic behavior. According to this proposal, two rapidly equilibrating forms of the enzyme, which differ in the degree of protonation of specific residues, differ in their ability to bind substrates. While the protonated form of the enzyme subsequently becomes inactive by isomerization and dissociation, this process is too slow to affect the kinetic results, making direct comparisons between the association-dissociation behavior and regulatory kinetic behavior invalid. The time dependence of the processes of inactivation or reactivation in the presence or absence of ligands and of the appearance of regulatory kinetic behavior is discussed in relation to their possible role in metabolic regulation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9395

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Shape of phosphofructokinase from Escherichia coli in solution.

Authors:  H H Paradies; W Vettermann; G Werz
Journal:  Protoplasma       Date:  1977       Impact factor: 3.356

Review 2.  Dysregulated pH: a perfect storm for cancer progression.

Authors:  Bradley A Webb; Michael Chimenti; Matthew P Jacobson; Diane L Barber
Journal:  Nat Rev Cancer       Date:  2011-08-11       Impact factor: 60.716

Review 3.  Preimplantation stress and development.

Authors:  Sky Feuer; Paolo Rinaudo
Journal:  Birth Defects Res C Embryo Today       Date:  2012-12

Review 4.  Allosteric regulatory properties of muscle phosphofructokinase.

Authors:  R G Kemp; L G Foe
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

Review 5.  Cancer cell behaviors mediated by dysregulated pH dynamics at a glance.

Authors:  Katharine A White; Bree K Grillo-Hill; Diane L Barber
Journal:  J Cell Sci       Date:  2017-02-15       Impact factor: 5.285

6.  Inositol 1,4-bisphosphate is an allosteric activator of muscle-type 6-phosphofructo-1-kinase.

Authors:  G W Mayr
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

7.  Identification of C-terminal motifs responsible for transmission of inhibition by ATP of mammalian phosphofructokinase, and their contribution to other allosteric effects.

Authors:  Oscar H Martínez-Costa; Carmen Hermida; Cristina Sánchez-Martínez; Belén Santamaría; Juan J Aragón
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

8.  Obfuscation of allosteric structure-function relationships by enthalpy-entropy compensation.

Authors:  V L Tlapak-Simmons; G D Reinhart
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

9.  The kinetics of effector binding to phosphofructokinase. The binding of Mg2+-1,N6-ethenoadenosine triphosphate to the catalytic site.

Authors:  D Roberts; G L Kellett
Journal:  Biochem J       Date:  1980-09-01       Impact factor: 3.857

10.  Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question.

Authors:  Khalid O Alfarouk; Daniel Verduzco; Cyril Rauch; Abdel Khalig Muddathir; H H Bashir Adil; Gamal O Elhassan; Muntaser E Ibrahim; Julian David Polo Orozco; Rosa Angela Cardone; Stephan J Reshkin; Salvador Harguindey
Journal:  Oncoscience       Date:  2014-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.